Showing results (11-20 of 94) with videos related to
Sort By:
Pageof 10
Clinical Rheumatology|November 27, 2016
Putting recommendations into practice: Australian rheumatologists' opinions on leflunomide use in rheumatoid arthritisAshley M Hopkins, Michael D Wiese, Catherine E O'Doherty, et al.BMC Pulmonary Medicine|September 29, 2016
Risk factors for development of pulmonary arterial hypertension in Australian systemic sclerosis patients: results from a large multicenter cohort studyKathleen Morrisroe, Molla Huq, Wendy Stevens, et al.Clinical and Experimental Rheumatology|July 28, 2016
Determinants of unemployment amongst Australian systemic sclerosis patients: results from a multicentre cohort studyKathleen Morrisroe, Molla Huq, Wendy Stevens, et al.Analytical and Bioanalytical Chemistry|July 7, 2022
Quantitation of methotrexate polyglutamates in human whole blood, erythrocytes and leukocytes collected via venepuncture and volumetric absorptive micro-sampling: a green LC-MS/MS-based methodDala N Daraghmeh, Mahin Moghaddami, Larisa Bobrovskaya, et al.Arthritis Care & Research|May 2, 2023
Barriers and Enablers in the Use of Parenteral Methotrexate in Rheumatoid Arthritis Patients: A Scoping ReviewJiun Ming Tan, Emily Reeve, Lauren Fraser, et al.British Journal of Clinical Pharmacology|January 27, 2016
A model-based evaluation of single metrics for discriminating changes in rheumatoid arthritis disease activityJessica Wojciechowski, Michael D Wiese, Susanna M Proudman, et al.British Journal of Clinical Pharmacology|November 14, 2014
A population model of early rheumatoid arthritis disease activity during treatment with methotrexate, sulfasalazine and hydroxychloroquineJessica Wojciechowski, Michael D Wiese, Susanna M Proudman, et al.Seminars in Arthritis and Rheumatism|October 22, 2016
Measures of disease status in systemic sclerosis: A systematic reviewTien Tay, Nava Ferdowsi, Murray Baron, et al.Seminars in Arthritis and Rheumatism|June 29, 2019
The neutrophil-lymphocyte ratio in early rheumatoid arthritis and its ability to predict subsequent failure of triple therapyDaniel Boulos, Susanna M Proudman, Robert G Metcalf, et al.Annals of the Rheumatic Diseases|April 26, 2012
Prevalence of coronary heart disease and cardiovascular risk factors in a national cross-sectional cohort study of systemic sclerosisGene-Siew Ngian, Joanne Sahhar, Susanna M Proudman, et al.Pageof 10